Weidong Zhong - Business-News-Today.com

TERN-201 NASH clinical trial : Terns reports positive results for phase 1 study

pharmanewsdaily - January 12, 2020 0

TERN-201 NASH clinical trial : Terns Pharmaceuticals said that an ongoing phase 1 trial of its semicarbazide-sensitive amine oxidase (SSAO) inhibitor TERN-201 in non-alcoholic steatohepatitis ... Read More

TERN-201 NASH clinical trial : Terns reports positive results for phase 1 study

Texas Instruments gets $1.6bn in CHIPS Act Funding to drive U.S. semiconductor expansion

Starbucks workers expand strike as tensions over wages and labor practices escalate

Sanofi strengthens cardiovascular portfolio with Aficamten rights in Greater China

News Corp agrees to Foxtel sale to DAZN Group in A$3.4bn deal

SmartStop Self Storage expands into Washington, D.C., and San Jose with premium facilities

Third Point to acquire AS Birch Grove to boost credit capabilities

Rocket Lab wraps up 2024 with Synspective satellite launch, achieves 60% growth in missions

Fleeing driver crashes truck into Texas mall, injuring five before fatal shooting

US Navy jet downed in Red Sea friendly fire incident

Tragic helicopter crash: Turkish hospital struck, all onboard killed

Rumble secures $775m investment from Tether to fuel decentralized growth

Novo Nordisk’s CagriSema demonstrates superior weight loss results in REDEFINE 1 trial

Volkswagen guarantees no layoffs for a decade in historic worker deal

Cosmo First introduces advanced paint protection films to redefine car care

Suraksha Diagnostic reports strong growth in Q2 and H1 FY25 financial results

Saksoft strengthens digital transformation portfolio with ZeTechno acquisition

Tragedy in Mohali: One dead in building collapse, rescue teams race against time

Seven Indian nationals injured in Germany’s Magdeburg attack: Government ensures assistance

Robin Uthappa issues clarification amid provident fund fraud case

US retaliates with precision strikes on Houthi targets after Tel Aviv missile attack